Log on / register
Feedback | Support | My details
A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis.
Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, Humala N, Thiyagarajan M, Wang J, Pasinetti GM
BMC Neurosci 2006, 7:29
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research    
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial
Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC
Nutrition & Metabolism 2009, 6:31 (10 August 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
2.


Review    
Hypometabolism as a therapeutic target in Alzheimer's disease
Costantini LC, Barr LJ, Vogel JL, Henderson ST
BMC Neuroscience 2008, 9(Suppl 2):S16 (3 December 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 2 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.